The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, according to a press release from CSL Behring. The approval was based on ...

The company announced that the US FDA approved Yeztugo ® (lenacapavir), Gilead Sciences, Inc. (NASDAQ:GILD)’s injectable HIV-1 capsid inhibitor, as pre-exposure prophylaxis (PrEP) in order to ...

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation ...

These ailments have accompanied humanity for thousands, even millions, of years—and they’re not done with us yet.

In 1999, the American Society of Health-System Pharmacists (ASHP) published therapeutic guidelines concerning stress ulcer prophylaxis.

Prospective trials are needed to investigate the value of prolonged anticoagulant therapy in patients with high factor VIII levels, but until these data are in hand, extended prophylaxis must be ...

Is lactulose an effective prophylaxis in the prevention of hepatic encephalopathy?

Chronic or recurring yeast infections can affect your daily life. Learn what causes them and what you can do to treat and prevent them.

Mycoplasma-induced rash and mucositis is a distinctive subset of reactive infectious mucocutaneous eruption identified in 2015 to differentiate it from other mucocutaneous disorders such as ...

Regarding the pediatric population, mold-active antifungal prophylaxis is recommended for pediatric patients at high risk of IFD, including a subgroup of children with ALL.

The US Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for sexually acquired HIV.